The deals will build on agreements the administration struck with 17 of the world’s largest drugmakers, including Pfizer, Eli Lilly and Amgen, starting last year.

The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.

Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of companies to twenty-six manufacturers. …